BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• 

  Deals

  Teva Wraps Up $703M Sale of Global Women’s Health Biz to CVC Capital

  The portfolio includes Ovaleap, Zoely, Seasonique, Colpotrophine, Actonel and additional products.

  February 1, 2018

   · 

  5 min read
• Business

  McKesson Reports Fiscal 2018 Third-Quarter Results

  McKesson today reported that revenues for the third quarter ended December 31, 2017, were $53.6 billion, up 7% compared to $50.1 billion a year ago.

  February 1, 2018

   · 

  50 min read
• Drug Development

  Panacea Pharma Completes Enrollment in Phase I Study of First-in-Class Cancer Vaccine Therapy in Patients with Persistent Prostate Cancer

  PAN-301-1 is a novel nanoparticle immunotherapy vaccine candidate targeting HAAH also known as ASPH.

  February 1, 2018

   · 

  6 min read
• Pharm Country

  Getinge USA Sales, LLC, Launches Maquet Moduevo Ceiling Supply Unit Product Line in United States

  Getinge, a leading global provider of innovative medical technology, today announced the U.S. launch of its Maquet Moduevo ceiling supply unit product line.

  February 1, 2018

   · 

  3 min read
• Biotech Bay

  Strategikon Advances Planning and Financial Management for Life Sciences With Launch of Clinical Maestro

  Strategikon Pharma today announced the release of the Sponsor Edition of the Clinical Maestro platform.

  February 1, 2018

   · 

  2 min read
• Business

  TraceLink Expands Leadership Team With New Senior VP of Engineering and New CTO Appointment

  TraceLink today announced two key new senior leadership appointments.

  February 1, 2018

   · 

  5 min read
• BioMidwest

  GTCR and Regatta Medical Announce Strategic Investment in Resonetics

  Going forward, the existing Resonetics management team, led by CEO Tom Burns, will continue in their existing roles as a subsidiary of Regatta Medical.

  February 1, 2018

   · 

  4 min read
• Business

  Avecia Announces Opening of Cambridge, MA Office

  Avecia announced today the opening of a new corporate office in Cambridge, MA, to support its operations and corporate development activities, and to be more accessible to clients.

  February 1, 2018

   · 

  1 min read
• Business

  Charles River Laboratories Makes Investments in High-Throughput Screening Infrastructure

  Charles River Laboratories today announced a new agreement which grants Charles River commercial access to AstraZeneca’s (NYSE: AZN) high-throughput screening (HTS) and compound management infrastructure.

  February 1, 2018

   · 

  3 min read
• Pharm Country

  Synergy Pharmaceuticals Achieves Cash Balance Requirement to Access Additional Capital

  Synergy today announced that it has met the cash balance requirement to access additional capital under the Term Loan Agreement dated as of September 1, 2017 with CRG Servicing LLC.

  February 1, 2018

   · 

  5 min read